CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in INVA — Innoviva, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,114,512
+$6,701,804 QoQ
Shares Held
1,163,713
+14.0% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99140681594173.ToString("F0")%
Shared 0.ToString("F0")%
None 0.008593184058268663.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. INVA ranks #48 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,114,512 | 1,163,713 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,412,708 | 1,021,146 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,942,999 | 873,589 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $15,143,058 | 753,761 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,055,764 | 609,805 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $10,889,935 | 627,662 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $14,140,635 | 732,296 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,629,416 | 831,062 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $14,152,824 | 928,663 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $14,969,474 | 933,259 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $10,363,460 | 797,803 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,691,967 | 682,794 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,598,665 | 586,548 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,253,125 | 471,934 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,388,839 | 464,155 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,629,217 | 449,134 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,006,971 | 413,797 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,965,463 | 519,737 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,915,854 | 533,564 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $7,409,547 | 552,539 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,523,158 | 545,871 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,686,365 | 458,948 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,373,920 | 418,557 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,130,271 | 438,503 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $4,851,058 | 412,505 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||